Artificial bladder developed in animal trials:
This article was originally published in Clinica
US scientists have reported that they have engineered new bladders in vivo in animals which functioned as well as the real thing. Researchers from Boston Children's Hospital and Harvard Medical School told delegates at the American Urological Association in San Diego last week that the bladder, made from a polymer matrix covered in bladder cells, began working successfully after four to six weeks. Clinical trials could begin in two years.
You may also be interested in...
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.
Sangamo licensed Biogen zinc finger protein transcription factor candidates in an alliance worth over $2bn. Exercising an option it gained in 2017, Takeda bought celiac disease-focused PvP Biologics for up to $330m in earn-outs. A strong showing of IPOs prompted biopharma financing to increase from last month.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.